Publications

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

 70
Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Tags:

Previous Article

Increased cholesterol synthesis drives neurotoxicity in multiple sclerosis

Next Article

Animal model for antitumor immunity in lung cancer

Related Posts

Neutrophil recruitment during intestinal inflammation primes Salmonella elimination by commensal E. coli in a context-dependent manner

Neutrophil recruitment during intestinal inflammation p...

 89

Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma

Gliocidin is a nicotinamide-mimetic prodrug that target...

 121

Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody- mediated complement deposition

Transfer of SARS-CoV-2 nucleocapsid protein to uninfec...

 319